Isis Pharmaceuticals Inc
ISIS:NASDAQ
| 最新 | 变化/%变化 | 股息收益率 | 交易量 | Avg Volume (10 day) |
| 17.63 | 0.00 0.00% | 0.00% | 0 | 1.6M |
市场数据至少延迟20分钟
Isis Pharmaceuticals Inc的最新新闻标题
Shares of Isis Pharmaceuticals Under Pressure, Down 1.4%
Isis Pharmaceuticals (NASDAQ:ISIS) is one of today's notable stocks in decline, down 1.4% to $17.50. The Dow is down 0.3% to 14,494 and the S&P; is currently down 0.2% to 1,559.
Isis Pharmaceuticals (NASDAQ:ISIS) is currently priced 21.9% above its average consensus analyst price target of $13.67. Isis Pharmaceuticals shares have support at the 50-day moving average (MA) of $14.42 and additional support at the 200-day MA of $12.27.
Isis Pharmaceuticals to Present at the 25th Annual ROTH Conference
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 25th Annual ROTH Conference on Tuesday, March 19, 2013 at 8:00 a.m. PT in Laguna Niguel, CA.
Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting
查看更多最新标题Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it will host an investor event and a live webcast on Thursday, March 21, 2013 at 7:30 a.m. Pacific Time to discuss the ISIS-SMNRx Phase 1 data presented at the 2013 American Academy of Neurology Annual Meeting.
公司背景
Isis Pharmaceuticals, Inc. develops therapeutic drugs inhibiting cell protein synthesis. The Company's principal activity is to develop and market RNA(RiboNucleicAcid)-based novel drugs to treat important diseases such as cardiovascular diseases, diabetes and asthma
买方价/量 -- / -- | 卖方价/量 -- / -- |
开盘价格 0.00 | 前收盘价格 17.63 |
当天最高 0.00 | 当天最低 0.00 |
52周高/日期 18.03 / 3/13/2013 | 52周低/日期 7.02 / 4/19/2012 |
% off 52wk High -2.22% | % off 52wk Low 151.14% |
贝他(5年) 1.0 | 市值 1.8B |
流通股数 101.8M | 波动平均(Volatility Avg) 55.40 |
每股收益(EPS)(TTM) -0.83 | 市盈率(P/E) Not Meaningful |
股息宣布日 -- | 股息收益率 0.00% |
除息日 -- | 登记日 -- |
支付数额 0.00 - -- | 支付日期 -- |
上次交易3/18/2013 4:00 PM ET | |
ISIS Isis Pharmaceuticals Inc 对比同行
| 同行 | |
|---|---|
ISIS Isis Pharmaceuticals Inc | 68.87% |
VIA Pharmaceuticals, Inc. | -37.50% |
Pfizer Inc. | 11.81% |
Merck & Co., Inc. | 6.57% |
ISIS Isis Pharmaceuticals Inc | 0.00% |
VIA Pharmaceuticals, Inc. | -- |
Pfizer Inc. | 3.42% |
Merck & Co., Inc. | 3.94% |
ISIS Isis Pharmaceuticals Inc | 0.00% |
VIA Pharmaceuticals, Inc. | 0.00% |
Pfizer Inc. | 0.00% |
Merck & Co., Inc. | 0.00% |